Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories

被引:50
|
作者
Caraballo, Isidoro [1 ]
机构
[1] Univ Seville, Iberoameri Swiss Ctr Dev Dosage Forms CISDEM, Dept Pharm & Pharmaceut Technol, E-41012 Seville, Spain
关键词
controlled release; critical points; formulation factors; hydrophilic matrices; hydroxypropyl methylcellulose; percolation threshold; PARTICLE-SIZE; HYDROPHILIC MATRICES; CRITICAL-POINTS; HYDROXYPROPYLMETHYLCELLULOSE MATRICES; DELIVERY SYSTEM; SOLUTE RELEASE; TABLETS; HPMC; HYDROCHLORIDE; FORMULATION;
D O I
10.1517/17425247.2010.528199
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Areas covered in this review: A new approach, proposed in 2004, based on percolation theory to explain the influence of the main formulation factors on drug release from HPMC matrices has been analyzed, paying attention to the advantages with respect to previous theories. What the reader will gain: The influence of especially important factors such as polymer concentration and particle size is now much better known thanks to these new theories. Take home message: To formulate a HPMC matrix, the system must be above the polymer's critical point, that is, allowing HPMC to act as outer phase. In this way, a coherent gel layer will be obtained because the first moment and the drug release will be controlled by this layer. Furthermore, knowing the critical points allows the vicinity of these points to be avoided, which are regions of high variability. In this way, robust dosage forms can be obtained.
引用
收藏
页码:1291 / 1301
页数:11
相关论文
共 50 条
  • [31] SUSTAINED-RELEASE FROM PRECIROL (GLYCEROL PALMITO-STEARATE) MATRIX - EFFECT OF MANNITOL AND HYDROXYPROPYL METHYLCELLULOSE ON THE RELEASE OF THEOPHYLLINE
    PARAB, PV
    OH, CK
    RITSCHEL, WA
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (8-9) : 1309 - 1327
  • [32] Influence of Hydroxypropyl Methylcellulose Molecular Weight Grade on Water Uptake, Erosion and Drug Release Properties of Diclofenac Sodium Matrix Tablets
    Akbari, Jafar
    Enayatifard, Reza
    Saeedi, Majid
    Saghafi, Massoud
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (05) : 535 - 541
  • [33] SOME FACTORS AFFECTING RELEASE OF A WATER-SOLUBLE DRUG FROM A COMPRESSED HYDROPHILIC MATRIX
    LAPIDUS, H
    LORDI, NG
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1966, 55 (08) : 840 - &
  • [34] Structural changes in pH-responsive gelatin/hydroxypropyl methylcellulose phthalate blends aimed at drug-release systems
    Nogami, Satoshi
    Kadota, Kazunori
    Uchiyama, Hiromasa
    Arima-Osonoi, Hiroshi
    Iwase, Hiroki
    Tominaga, Taiki
    Yamada, Takeshi
    Takata, Shin-ichi
    Shibayama, Mitsuhiro
    Tozuka, Yuichi
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 190 : 989 - 998
  • [35] MATRIX FACTORS AFFECTING CONTROLLED RELEASE OF PESTICIDES FROM ELASTOMERS
    CARDARELLI, NF
    KANAKKANATT, SV
    WALKER, KE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1977, 173 (MAR20): : 15 - 15
  • [36] MATRIX TYPE CONTROLLED RELEASE SYSTEMS .1. EFFECT OF PERCOLATION ON DRUG DISSOLUTION KINETICS
    BONNY, JD
    LEUENBERGER, H
    PHARMACEUTICA ACTA HELVETIAE, 1991, 66 (5-6): : 160 - 164
  • [37] Using the percolation theory to explain the release behavior from inert matrix systems
    FernandezHervas, MJ
    Vela, MT
    GonzalezRodriguez, MLG
    Rabasco, AM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (03) : 201 - 210
  • [38] PERCOLATION THEORY - APPLICATION TO THE STUDY OF THE RELEASE BEHAVIOR FROM INERT MATRIX SYSTEMS
    CARABALLO, I
    FERNANDEZAREVALO, M
    HOLGADO, MA
    RABASCO, AM
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 96 (1-3) : 175 - 181
  • [39] INFLUENCE OF IONIC-STRENGTH ON MATRIX INTEGRITY AND DRUG RELEASE FROM HYDROXYPROPYL CELLULOSE COMPACTS
    JOHNSON, JL
    HOLINEJ, J
    WILLIAMS, MD
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 90 (02) : 151 - 159
  • [40] SOME FACTORS AFFECTING THE RELEASE OF DRUG FROM MEMBRANE COATED SLOW RELEASE TABLETS
    MARINI, JO
    MENDES, RW
    REKHI, GS
    JAMBHEKAR, SS
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (06) : 865 - 877